BACKGROUND: The role of the innate immune system in the development of thrombotic microangiopathy (TM) after alpha1,3-galactosyltransferase gene-knockout (GTKO) pig organ transplantation in primates is uncertain. METHODS: Twelve organs (nine hearts, three kidneys) from GTKO pigs were transplanted into baboons that received no immunosuppressive therapy, partial regimens, or a full regimen based on costimulation blockade. After graft failure, histologic and immunohistologic examinations were carried out. RESULTS: Graft survival of less than 1 day was prolonged to 2 to 12 days with partial regimens (acute humoral xenograft rejection) and to 5 and 8 weeks with the full regimen (TM). Clinical or laboratory features of consumptive coagulopathy occurred in 7 of 12 baboons. Immunohistochemistry demonstrated IgM, IgG, and complement deposition in most cases. Histopathology demonstrated neutrophil and macrophage infiltrates, intravascular fibrin deposition, and platelet aggregation (TM). Grafts showed expression of primate tissue factor (TF), with increased mRNA levels, and TF was also expressed on baboon macrophages/monocytes infiltrating the graft. CONCLUSIONS: Our data suggest that (1) irrespective of the presence or absence of the adaptive immune response, early or late xenograft rejection is associated with activation of the innate immune system; and (2) porcine endothelial cell activation and primate TF expression by recipient innate immune cells may both contribute to the development of TM.
BACKGROUND: The role of the innate immune system in the development of thrombotic microangiopathy (TM) after alpha1,3-galactosyltransferase gene-knockout (GTKO) pig organ transplantation in primates is uncertain. METHODS: Twelve organs (nine hearts, three kidneys) from GTKO pigs were transplanted into baboons that received no immunosuppressive therapy, partial regimens, or a full regimen based on costimulation blockade. After graft failure, histologic and immunohistologic examinations were carried out. RESULTS: Graft survival of less than 1 day was prolonged to 2 to 12 days with partial regimens (acute humoral xenograft rejection) and to 5 and 8 weeks with the full regimen (TM). Clinical or laboratory features of consumptive coagulopathy occurred in 7 of 12 baboons. Immunohistochemistry demonstrated IgM, IgG, and complement deposition in most cases. Histopathology demonstrated neutrophil and macrophage infiltrates, intravascular fibrin deposition, and platelet aggregation (TM). Grafts showed expression of primate tissue factor (TF), with increased mRNA levels, and TF was also expressed on baboon macrophages/monocytes infiltrating the graft. CONCLUSIONS: Our data suggest that (1) irrespective of the presence or absence of the adaptive immune response, early or late xenograft rejection is associated with activation of the innate immune system; and (2) porcine endothelial cell activation and primate TF expression by recipient innate immune cells may both contribute to the development of TM.
Authors: Shounan Yi; Wayne J Hawthorne; Anne M Lehnert; Hong Ha; Jeferey Kwok Wah Wong; Nico van Rooijen; Kelly Davey; Anita T Patel; Stacey N Walters; Abhilash Chandra; Philip J O'Connell Journal: J Immunol Date: 2003-03-01 Impact factor: 5.422
Authors: Yau-Lin Tseng; Kenji Kuwaki; Frank J M F Dor; Akira Shimizu; Stuart Houser; Yosuke Hisashi; Kazuhiko Yamada; Simon C Robson; Michel Awwad; Henk-Jan Schuurman; David H Sachs; David K C Cooper Journal: Transplantation Date: 2005-11-27 Impact factor: 4.939
Authors: Gang Chen; Hua Qian; Thomas Starzl; Hongtao Sun; Bertha Garcia; Ximo Wang; Yishai Wise; Yuanqing Liu; Ying Xiang; Laura Copeman; Weihua Liu; Anthony Jevnikar; William Wall; David K C Cooper; Noriko Murase; Yifan Dai; Wanyu Wang; Yuliang Xiong; David J White; Robert Zhong Journal: Nat Med Date: 2005-11-27 Impact factor: 53.440
Authors: Yifan Dai; Todd D Vaught; Jeremy Boone; Shu-Hung Chen; Carol J Phelps; Suyapa Ball; Jeff A Monahan; Peter M Jobst; Kenneth J McCreath; Ashley E Lamborn; Jamie L Cowell-Lucero; Kevin D Wells; Alan Colman; Irina A Polejaeva; David L Ayares Journal: Nat Biotechnol Date: 2002-03 Impact factor: 54.908
Authors: Carol J Phelps; Chihiro Koike; Todd D Vaught; Jeremy Boone; Kevin D Wells; Shu-Hung Chen; Suyapa Ball; Susan M Specht; Irina A Polejaeva; Jeff A Monahan; Pete M Jobst; Sugandha B Sharma; Ashley E Lamborn; Amy S Garst; Marilyn Moore; Anthony J Demetris; William A Rudert; Rita Bottino; Suzanne Bertera; Massimo Trucco; Thomas E Starzl; Yifan Dai; David L Ayares Journal: Science Date: 2002-12-19 Impact factor: 47.728
Authors: Donna Kolber-Simonds; Liangxue Lai; Steven R Watt; Maria Denaro; Scott Arn; Monica L Augenstein; Jeffery Betthauser; David B Carter; Julia L Greenstein; Yanhong Hao; Gi-Sun Im; Zhonghua Liu; Greg D Mell; Clifton N Murphy; Kwang-Wook Park; August Rieke; David J J Ryan; David H Sachs; Erik J Forsberg; Randall S Prather; Robert J Hawley Journal: Proc Natl Acad Sci U S A Date: 2004-05-03 Impact factor: 11.205
Authors: Kenji Kuwaki; Christoph Knosalla; Frank J M F Dor; Bernd Gollackner; Yau-Lin Tseng; Stuart Houser; Nicolas Mueller; Derek Prabharasuth; Amy Alt; Kathy Moran; Jane Cheng; Amir Behdad; David H Sachs; Jay A Fishman; Henk-Jan Schuurman; Michel Awwad; David K C Cooper Journal: Am J Transplant Date: 2004-03 Impact factor: 8.086
Authors: Christoph Knosalla; Bernd Gollackner; Leo Bühler; Nicolas J Mueller; Stuart Houser; Shamila Mauiyyedi; David H Sachs; Simon C Robson; Jay Fishman; Henk-Jan Schuurman; Michel Awwad; David K C Cooper Journal: Am J Transplant Date: 2003-12 Impact factor: 8.086
Authors: C C Lin; M Ezzelarab; R Shapiro; B Ekser; C Long; H Hara; G Echeverri; C Torres; H Watanabe; D Ayares; A Dorling; D K C Cooper Journal: Am J Transplant Date: 2010-07 Impact factor: 8.086
Authors: Hidetaka Hara; Andrew Bentall; Cassandra Long; Jason Fang; Oleg Andreyev; John Lunz; Mohamed Ezzelarab; Kareem M Abu-Elmagd; Ron Shapiro; David Ayares; Mark Stegall; David K C Cooper Journal: Xenotransplantation Date: 2013-09-03 Impact factor: 3.907
Authors: Tao Li; Whayoung Lee; Hidetaka Hara; Cassandra Long; Mohamed Ezzelarab; David Ayares; Hai Huang; Yi Wang; Charles T Esmon; David K C Cooper; Hayato Iwase Journal: Transplantation Date: 2017-10 Impact factor: 4.939
Authors: Agnes M Azimzadeh; Sean S Kelishadi; Mohamed B Ezzelarab; Avneesh K Singh; Tiffany Stoddard; Hayato Iwase; Tianshu Zhang; Lars Burdorf; Evelyn Sievert; Chris Avon; Xiangfei Cheng; David Ayares; Keith A Horvath; Philip C Corcoran; Muhammad M Mohiuddin; Rolf N Barth; David K C Cooper; Richard N Pierson Journal: Xenotransplantation Date: 2015-07-14 Impact factor: 3.907
Authors: Hayato Iwase; Burcin Ekser; Vikas Satyananda; Jay Bhama; Hidetaka Hara; Mohamed Ezzelarab; Edwin Klein; Robert Wagner; Cassandra Long; Jnanesh Thacker; Jiang Li; Hao Zhou; Maolin Jiang; Santosh Nagaraju; Huidong Zhou; Massimiliano Veroux; Pietro Bajona; Martin Wijkstrom; Yi Wang; Carol Phelps; Nikolai Klymiuk; Eckhard Wolf; David Ayares; David K C Cooper Journal: Xenotransplantation Date: 2015-04-03 Impact factor: 3.907
Authors: John M Stewart; Alice F Tarantal; Wayne J Hawthorne; Evelyn J Salvaris; Philip J O'Connell; Mark B Nottle; Anthony J F d'Apice; Peter J Cowan; Mary Kearns-Jonker Journal: Xenotransplantation Date: 2014-05-08 Impact factor: 3.907
Authors: Mohamed B Ezzelarab; Burcin Ekser; Gabriel Echeverri; Hidetaka Hara; Corin Ezzelarab; Cassandra Long; Pietro Bajona; Bertha Garcia; Noriko Murase; David Ayares; David K C Cooper Journal: Xenotransplantation Date: 2012 Jul-Aug Impact factor: 3.907
Authors: Burcin Ekser; Christopher Burlak; Joshua P Waldman; Andrew J Lutz; Leela L Paris; Massimiliano Veroux; Simon C Robson; Michael A Rees; David Ayares; Bruno Gridelli; A Joseph Tector; David Kc Cooper Journal: Expert Rev Clin Immunol Date: 2012-09 Impact factor: 4.473